Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer EGFR 2026

D. Ross Camidge

罗斯·卡米奇

MB BChir, PhD, FRCP, FACP

🏢University of Colorado Cancer Center(科罗拉多大学癌症中心)🌐USA

Joyce Zeff Chair in Lung Cancer Research; Director, Thoracic Oncology Clinical and Clinical Translational Research Programs乔伊斯·泽夫肺癌研究主席;胸部肿瘤临床及转化研究项目主任

82
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

One of the most prolific thoracic oncology clinical researchers globally. Led the PROFILE crizotinib trials revolutionizing ALK-positive NSCLC treatment, contributed major data on lorlatinib and EGFR resistance mechanisms, and pioneered understanding of CNS involvement in TKI-treated NSCLC.

Share:

🧪Research Fields 研究领域

ALK Crizotinib PROFILEALK克唑替尼PROFILE
Lorlatinib劳拉替尼
EGFR ResistanceEGFR耐药
NSCLC Targeted Therapy非小细胞肺癌靶向治疗
Brain Metastases脑转移

🎓Key Contributions 主要贡献

PROFILE Crizotinib Trials

Principal investigator for PROFILE 1014, demonstrating crizotinib superiority over chemotherapy in ALK-positive NSCLC, establishing ALK as the second major oncogenic driver after EGFR in NSCLC.

EGFR Resistance and Next-Generation TKIs

Published landmark studies on mechanisms of acquired resistance to EGFR TKIs and strategies using third-generation inhibitors and combination approaches to overcome resistance in advanced NSCLC.

Representative Works 代表性著作

[1]

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer (PROFILE 1014)

New England Journal of Medicine (2014)

Definitive phase III trial establishing crizotinib as standard of care for previously untreated ALK-positive NSCLC.

[2]

Lorlatinib in Non–Small-Cell Lung Cancer with ALK or ROS1 Rearrangement: An International, Multicenter, Open-Label, Single-Arm, Phase 1/2 Trial

Lancet Oncology (2018)

Pivotal study establishing lorlatinib activity across multiple ALK resistance mutations, supporting approval of next-generation ALK TKI.

🏆Awards & Recognition 奖项与荣誉

🏆IASLC Paul A. Bunn Jr. Award
🏆ASCO Distinguished Scientist Award
🏆Colorado Cancer Research Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 罗斯·卡米奇 的研究动态

Follow D. Ross Camidge's research updates

留下邮箱,当我们发布与 D. Ross Camidge(University of Colorado Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment